156 related articles for article (PubMed ID: 38631840)
1. De-imFAR phase II project: a study protocol for a cluster randomised implementation trial to evaluate the effectiveness of de-implementation strategies to reduce low-value statin prescribing in the primary prevention of cardiovascular disease.
Sanchez A; Pijoan JI; Sainz de Rozas R; Lekue I; San Vicente R; Quindimil JA; Rotaeche R; Etxeberria A; Mozo C; Martinez-Cengotitabengoa M; Monge M; Gómez-Ramírez C; Samper R; Ogueta Lana M; Celorrio S; Merino-Inda N; Llarena M; Gonzalez Saenz de Tejada M; García-Alvarez A; Grandes G
BMJ Open; 2024 Apr; 14(4):e078692. PubMed ID: 38631840
[TBL] [Abstract][Full Text] [Related]
2. Addressing low-value pharmacological prescribing in primary prevention of CVD through a structured evidence-based and theory-informed process for the design and testing of de-implementation strategies: the DE-imFAR study.
Sanchez A; Pijoan JI; Pablo S; Mediavilla M; de Rozas RS; Lekue I; Gonzalez-Larragan S; Lantaron G; Argote J; García-Álvarez A; Latorre PM; Helfrich CD; Grandes G
Implement Sci; 2020 Jan; 15(1):8. PubMed ID: 31969175
[TBL] [Abstract][Full Text] [Related]
3. Applying the behavior change wheel to design de-implementation strategies to reduce low-value statin prescription in primary prevention of cardiovascular disease in primary care.
Sanchez A; Elizondo-Alzola U; Pijoan JI; Mediavilla MM; Pablo S; Sainz de Rozas R; Lekue I; Gonzalez-Larragan S; Llarena M; Larrañaga O; Helfrich CD; Grandes G
Front Med (Lausanne); 2022; 9():967887. PubMed ID: 36314033
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Scale-up of the Australian Fans in Training (Aussie-FIT) men's health behaviour change program: a protocol for a randomised controlled hybrid effectiveness-implementation trial.
McDonald MD; Brickley B; Pavey T; Smith JA; Maiorana A; McCaffrey T; Hillis G; Bonson J; Chih HJ; Gupta H; Holmes S; Hunt K; Kerr DA; Kwaśnicka D; Makate M; McVeigh J; Moullin JC; Smith BJ; Wharton L; Wharton N; Quested E
BMJ Open; 2023 Oct; 13(10):e078302. PubMed ID: 37879681
[TBL] [Abstract][Full Text] [Related]
6. Cohort study investigating the relationship between cholesterol, cardiovascular risk score and the prescribing of statins in UK primary care: study protocol.
Finnikin S; Ryan R; Marshall T
BMJ Open; 2016 Nov; 6(11):e013120. PubMed ID: 27856481
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
8. Engaging primary care professionals in collaborative processes for optimising type 2 diabetes prevention practice: the PREDIAPS cluster randomised type II hybrid implementation trial.
Sanchez A; Grandes G; Pablo S; Espinosa M; Torres A; García-Alvarez A;
Implement Sci; 2018 Jul; 13(1):94. PubMed ID: 29996928
[TBL] [Abstract][Full Text] [Related]
9. Selective prevention of cardiovascular disease using integrated lifestyle intervention in primary care: protocol of the Healthy Heart stepped-wedge trial.
Bonten TN; Verkleij SM; van der Kleij RM; Busch K; van den Hout WB; Chavannes NH; Numans ME
BMJ Open; 2021 Jul; 11(7):e043829. PubMed ID: 34244248
[TBL] [Abstract][Full Text] [Related]
10. Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial).
Zoungas S; Curtis A; Spark S; Wolfe R; McNeil JJ; Beilin L; Chong TT; Cloud G; Hopper I; Kost A; Nelson M; Nicholls SJ; Reid CM; Ryan J; Tonkin A; Ward SA; Wierzbicki A;
BMJ Open; 2023 Apr; 13(4):e069915. PubMed ID: 37012015
[TBL] [Abstract][Full Text] [Related]
11. Knowledge support for optimising antibiotic prescribing for common infections in general practices: evaluation of the effectiveness of periodic feedback, decision support during consultations and peer comparisons in a cluster randomised trial (BRIT2) - study protocol.
van Staa T; Sharma A; Palin V; Fahmi A; Cant H; Zhong X; Jury F; Gold N; Welfare W; Ashcroft D; Tsang JY; Elliott RA; Sutton C; Armitage C; Couch P; Moulton G; Tempest E; Buchan IE
BMJ Open; 2023 Aug; 13(8):e076296. PubMed ID: 37607793
[TBL] [Abstract][Full Text] [Related]
12. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
Palmer MJ; Machiyama K; Woodd S; Gubijev A; Barnard S; Russell S; Perel P; Free C
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012675. PubMed ID: 33769555
[TBL] [Abstract][Full Text] [Related]
13. Tackling statin intolerance with n-of-1 trials (TaSINI) in primary care: protocol for a feasibility randomised trial to increase statin adherence.
Tudor K; Brooks J; Howick J; Fox R; Aveyard P
BMJ Open; 2020 Feb; 10(2):e033070. PubMed ID: 32051312
[TBL] [Abstract][Full Text] [Related]
14. Discontinuing statins or not in the elderly? Study protocol for a randomized controlled trial.
Bonnet F; Bénard A; Poulizac P; Afonso M; Maillard A; Salvo F; Berdaï D; Salles N; Rousselot N; Marchi S; Hayes N; Joseph JP
Trials; 2020 Apr; 21(1):342. PubMed ID: 32307005
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a toolkit to improve cardiovascular disease screening and treatment for people with type 2 diabetes: protocol for a cluster-randomized pragmatic trial.
Shah BR; Bhattacharyya O; Yu C; Mamdani M; Parsons JA; Straus SE; Zwarenstein M
Trials; 2010 Apr; 11():44. PubMed ID: 20416080
[TBL] [Abstract][Full Text] [Related]
16. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.
Zhan S; Tang M; Liu F; Xia P; Shu M; Wu X
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012502. PubMed ID: 30480766
[TBL] [Abstract][Full Text] [Related]
17. Type-2 diabetes primary prevention program implemented in routine primary care: a process evaluation study.
Sánchez A; Silvestre C; Campo N; Grandes G;
Trials; 2016 May; 17(1):254. PubMed ID: 27206733
[TBL] [Abstract][Full Text] [Related]
18. Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling.
Perera R; McFadden E; McLellan J; Lung T; Clarke P; Pérez T; Fanshawe T; Dalton A; Farmer A; Glasziou P; Takahashi O; Stevens J; Irwig L; Hirst J; Stevens S; Leslie A; Ohde S; Deshpande G; Urayama K; Shine B; Stevens R
Health Technol Assess; 2015 Dec; 19(100):1-401, vii-viii. PubMed ID: 26680162
[TBL] [Abstract][Full Text] [Related]
19. Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease.
Flowers N; Hartley L; Todkill D; Stranges S; Rees K
Cochrane Database Syst Rev; 2014; 2014(12):CD010405. PubMed ID: 25474484
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
